ons in diabetes, obesity and Novo Nordisk ® sity care #1 120% 100% 80% 60% 40% alue: 146.9% 20% 0% Nov 2024 rket share (RHS) et position DKK billion 100 80 Haemophilia #3 50% 40% 60 30% 40 20% 20 CAGR 3 value: 4.5% 10% 0 FY 2019 Market value FY 0% 2023 NN value market share (RHS) Global market position
Download PDF file